Cargando…

Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment

In an unbiased approach to biomarker discovery, we applied a highly multiplexed proteomic technology (SOMAscan, SomaLogic, Inc, Boulder, CO) to understand changes in proteins from paired serum samples at enrollment and after 8 weeks of TB treatment from 39 patients with pulmonary TB from Kampala, Ug...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Groote, Mary A., Nahid, Payam, Jarlsberg, Leah, Johnson, John L., Weiner, Marc, Muzanyi, Grace, Janjic, Nebojsa, Sterling, David G., Ochsner, Urs A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630118/ https://www.ncbi.nlm.nih.gov/pubmed/23637781 http://dx.doi.org/10.1371/journal.pone.0061002

Ejemplares similares

Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary Tuberculosis
por: De Groote, Mary A., et al.
Publicado: (2017)

Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection
por: De Groote, Mary Ann, et al.
Publicado: (2017)

Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection
por: Mehaffy, Carolina, et al.
Publicado: (2020)

Potential of High-Affinity, Slow Off-Rate Modified Aptamer Reagents for Mycobacterium tuberculosis Proteins as Tools for Infection Models and Diagnostic Applications
por: Russell, Theresa M., et al.
Publicado: (2017)

Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
por: Alipanah, Narges, et al.
Publicado: (2018)

Pyrazinamide Resistance, Mycobacterium tuberculosis Lineage and Treatment Outcomes in San Francisco, California
por: Budzik, Jonathan M., et al.
Publicado: (2014)

Childhood Tuberculosis in Northern Viet Nam: A Review of 103 Cases
por: Blount, Robert J., et al.
Publicado: (2014)

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
por: Nahid, Payam, et al.
Publicado: (2011)

Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Racial Differences in Tuberculosis Infection in United States Communities: The Coronary Artery Risk Development in Young Adults Study
por: Nahid, Payam, et al.
Publicado: (2011)

The threat of persistent bacteria and fungi contamination in tuberculosis sputum cultures
por: Muzanyi, Grace, et al.
Publicado: (2021)

Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
por: Rohloff, John C, et al.
Publicado: (2014)

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
por: Sigal, G.B., et al.
Publicado: (2017)

Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
por: Scriba, Thomas J., et al.
Publicado: (2017)

Collaborative research to respond to the HIV epidemic: a case of Uganda (Makerere University)-Case Western Reserve University Research Collaboration 1988–2021
por: Muzanyi, Grace, et al.
Publicado: (2022)

Specific capture and detection of Staphylococcus aureus with high-affinity modified aptamers to cell surface components
por: Baumstummler, A, et al.
Publicado: (2014)

Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum
por: Mehaffy, Carolina, et al.
Publicado: (2017)

Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region
por: Jarsberg, Leah G., et al.
Publicado: (2021)

Predictors of recurrent TB in sputum smear and culture positive adults: a prospective cohort study
por: Muzanyi, Grace, et al.
Publicado: (2019)

Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis
por: Kedia, Komal, et al.
Publicado: (2018)

Association between Diabetes Mellitus and Tuberculosis in United States-Born and Foreign-Born Populations in San Francisco
por: Suwanpimolkul, Gompol, et al.
Publicado: (2014)

Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
por: Velásquez, Gustavo E., et al.
Publicado: (2023)

Serum biomarkers of Burkholderia mallei infection elucidated by proteomic imaging of skin and lung abscesses
por: Glaros, Trevor G, et al.
Publicado: (2015)

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis
por: Nahid, P., et al.
Publicado: (2018)

Level of education and preferred language of informed consent for clinical research in a multi-lingual community
por: Muzanyi, Grace, et al.
Publicado: (2020)

Influence of M. tuberculosis Lineage Variability within a Clinical Trial for Pulmonary Tuberculosis
por: Nahid, Payam, et al.
Publicado: (2010)

Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy
por: Fitzgerald, Bryna L., et al.
Publicado: (2018)

Serum Exosomal miRNAs Are Associated with Active Pulmonary Tuberculosis
por: Alipoor, Shamila D., et al.
Publicado: (2019)

Recent advances towards tuberculosis control: vaccines and biomarkers
por: Weiner, J, et al.
Publicado: (2014)

Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota
por: Lomeli, Barbara K., et al.
Publicado: (2019)

Serum Protein Electrophoresis Bands As Biomarkers for Drug-Sensitive Pulmonary Tuberculosis
por: Sinha, Poonam, et al.
Publicado: (2023)

Elucidation and Chemical Modulation of Sulfolipid-1 Biosynthesis in Mycobacterium tuberculosis
por: Seeliger, Jessica C., et al.
Publicado: (2012)

Elucidating the pathogenic and biomarker potentials of FOXG1 in glioblastoma
por: Richard, Seidu A., et al.
Publicado: (2020)

Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy”
por: Fitzgerald, Bryna L., et al.
Publicado: (2019)

Circulating Cell-Free RNA in Blood as a Host Response Biomarker for the Detection of Tuberculosis
por: Chang, Adrienne, et al.
Publicado: (2023)

An Elucidation of Neutrophil Functions against Mycobacterium tuberculosis Infection
por: Morris, Devin, et al.
Publicado: (2013)

Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis
por: Gewitz, Andrew D., et al.
Publicado: (2021)

Plasma Biomarkers of Reticular Pseudodrusen and the Risk of Progression to Advanced Age-Related Macular Degeneration
por: Lynch, Anne M., et al.
Publicado: (2020)

Serum Cytokine Biomarkers for Use in Diagnosing Pulmonary Tuberculosis versus Chronic Pulmonary Aspergillosis
por: Ren, Weicong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ip8s4s2r5m5b5espun0vvlq6uv